Phase III Study by the Norwegian Lung Cancer Study Group: Pemetrexed Plus Carboplatin Compared With Gemcitabine Plus Carboplatin As First-Line Chemotherapy in Advanced Non–Small-Cell Lung Cancer
GRØNBERG, Bjorn H, BREMNES, Roy M, WAMMER, Finn, AASEBØ, Ulf, SUNDSTRØM, Stein, FLØTTEN, Øystein, AMUNDSEN, Tore, BRUNSVIG, Paal Fr, HJELDE, Harald H, KAASA, Stein, VON PLESSEN, Christian, STORNES, Froydis, TOLLALI, Terje
Published in Journal of clinical oncology (01.07.2009)
Published in Journal of clinical oncology (01.07.2009)
Get full text
Journal Article
Lifestyle modification for weight loss: Effects on cardiorespiratory capacity in patients with class II and class III obesity
Wammer, Finn, Haberberger, Andrea, Linge, Anita Dyb, Myklebust, Tor Åge, Vemøy, Sveinung, Hoff, Dag Arne Lihaug
Published in Obesity science & practice (01.02.2022)
Published in Obesity science & practice (01.02.2022)
Get full text
Journal Article
A3-04: A phase III study by the Norwegian Lung Cancer Group: Pemetrexed + carboplatin vs. gemcitabine + carboplatin as first-line chemotherapy in stage IIIB/IV non-small cell lung cancer
Grønberg, Bjørn H., Bremnes, Roy, Aasebø, Ulf, Brunsvig, Paal, Fløtten, Øystein, Hjelde, Harald, Wammer, Finn, Stornes, Frøydis, Tollåli, Terje, Sundstrøm, Stein
Published in Journal of thoracic oncology (01.08.2007)
Published in Journal of thoracic oncology (01.08.2007)
Get full text
Journal Article